文献速递肿瘤 PET/CT

肝血管瘤中18F-AIF-FAPI-04摄取增高

Elevated 18 F-AIF-FAPI-04 Uptake in Hepatic Hemangioma.
PubMed 文献 · Clin Nucl Med · 2023-11-24

一名67岁女性经活检诊断为肝内胆管细胞癌(CCC),同时有3年肝血管瘤病史,接受了18F-FDG和18F-AIF-FAPI-04 PET/CT检查。18F-FDG PET/CT显示CCC摄取增高而血管瘤无摄取,但18F-AIF-FAPI-04 PET/CT显示CCC摄取阴性而血管瘤摄取浓聚。本病例提示肝血管瘤可表现为18F-AIF-FAPI-04摄取增高,最终诊断需谨慎。

要点

  • 肝血管瘤可表现为18F-AIF-FAPI-04摄取浓聚。
  • 肝血管瘤在18F-FDG PET/CT上无摄取。
  • 18F-AIF-FAPI-04 PET/CT诊断需谨慎。

核心结论

  • 本病例提示肝血管瘤可表现为18F-AIF-FAPI-04摄取浓聚,最终诊断需谨慎。

研究设计与样本

  • 病例报告:一名67岁女性,经活检诊断为肝内胆管细胞癌,有3年肝血管瘤病史,接受18F-FDG和18F-AIF-FAPI-04 PET/CT检查。

主要发现

  • 18F-FDG PET/CT显示肝内胆管细胞癌摄取增高,肝血管瘤无摄取。
  • 18F-AIF-FAPI-04 PET/CT显示肝内胆管细胞癌摄取阴性,肝血管瘤摄取浓聚。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 67-year-old woman who was diagnosed with intrahepatic cholangiocellular carcinoma (CCC) by biopsy underwent 18 F-FDG and 18 F-AIF-FAPI-04 PET/CT for initial and treatment assessment. In addition to CCC, she had a history of hepatic hemangioma for 3 years. 18 F-FDG PET/CT images showed increased uptake in CCC, but no uptake in hemangiomas. However, images on 18 F-AIF-FAPI-04 PET/CT indicated negative 18 F-AIF-FAPI-04 uptake in CCC, but intense activity in hemangiomas. Our case illustrates that hepatic hemangioma demonstrated intense 18 F-AIF-FAPI-04 uptake, and final diagnosis should be made with caution.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sun Y, Cai X, Wang Z, et al. Elevated 18 F-AIF-FAPI-04 Uptake in Hepatic Hemangioma. Clin Nucl Med. 2023. PMID: 38015630. doi:10.1097/RLU.0000000000004965

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。